Besides its circulating insulin-lowering effects that reduce fasting blood glucose levels, basic investigations demonstrated that METF also inhibited the growth of various human cancer cell types, such as thyroid [23], prostate [24], gastric [25], breast [26] and glioblastoma [27]. The gene discussed is INS; the disease is cancer.